ASSESSMENT OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY

Abstract

Background: The presence of nonalcoholic fatty liver disease (NAFLD) can raise the risk of cardiovascular disease in 
individuals with type 2 diabetes mellitus. Liver disease deaths can increase up to 22 times in persons with type 2 
diabetes mellitus. 
Aim: The purpose of this study was to evaluate liver involvement in individuals with type 2 diabetes mellitus and 
investigate the relationship between various cardiovascular parameters and non-alcoholic fatty liver disease in these 
individuals.  
Methods: 75 individuals with type 2 diabetes mellitus and fatty liver alterations on ultrasound were included in this 
prospective clinical investigation, and the relationship between these changes and cardiovascular changes was 
evaluated.  
Results: Based on diabetes duration, ischemia changes on ECG, and the highest prevalence of LVDD in subjects with 
HbA1c of 7.1–8, hypertension is considerably greater in persons with fatty liver compared to subjects without fatty 
liver, and most subjects with diabetes have had the disease for 5–10 years. A total of 78.66% (n=59) study individuals 
had hypertension, with 13.33% (n=10) having grade 0 hypertension, 45.33% (n=34) having grade 1 hypertension, and 
20% (n=15) having grade 2 hypertension. Grade 0, 1, 2, and 3 hypertension was observed in 10.66% (n = 8), 10.66% (n 
= 8), and 0 study subjects, respectively, in non-fatty liver subjects; a total of 21.33% (n = 16) study subjects had this 
condition. With p<0.0001, this difference was statistically significant.  
Results: The current study comes to the conclusion that individuals with type 2 diabetes mellitus primarily displayed 
left ventricular diastolic dysfunction on echocardiographic examinations.